|
|
Steve Tablak has been a successful healthcare entrepreneur building highly valued companies in diagnostics. As Chairman and CEO, he led GeneWEAVE from seed stage to exit in four years. The $425m acquisition of GeneWEAVE was the highest valuation ever for a pre-commercial Molecular Diagnostics (MDx) company. He was also the CEO and founder of Tamtron and took the company from an idea drawn on a napkin to a greatly valued exit (60x cash flow). The team developed the highly acclaimed PowerPath software for the management of pathology laboratories (cancer diagnostics). In a three year period after launch, PowerPath was adopted by more than one third of the top Cancer Centers in the U.S. (as rated by US New & World Report) and had obtained more than 12% of the overall U.S. market. Steve has worked in leadership positions in companies ranging from startups to the largest biotech company in the world. His deep intellectual curiosity has taken him on a journey to diverse areas from cancer (diagnostics and treatment) to infectious disease. With his various roles, he has taken deep dives into enterprise software, molecular and cellular biology and mechanical engineering; all the while maintaining strong management and fiscal discipline. In each case, he has used his leadership talents to create passionate, high performing teams focused on the strategic objectives that create value for the shareholders.
Steve continues to openly share his knowledge with entrepreneurs such that they might also create valuable companies that can improve the lives of patients throughout the world. He continues to serve as an advisor and board member for a number of startups. As a guest lecturer on entrepreneurship at UC Berkeley’s Haas School of Business for more than 15 years, Steve is fond of quoting one of his mentors in saying, “I hope through my sharing, young founders will have the benefit of only making original mistakes.”
Steve continues to openly share his knowledge with entrepreneurs such that they might also create valuable companies that can improve the lives of patients throughout the world. He continues to serve as an advisor and board member for a number of startups. As a guest lecturer on entrepreneurship at UC Berkeley’s Haas School of Business for more than 15 years, Steve is fond of quoting one of his mentors in saying, “I hope through my sharing, young founders will have the benefit of only making original mistakes.”